RISCHIN, D.; MIGDEN, M. R.; CHANG, A. L. S.; AL., E. Primary Analysis of Phase 2 Results for Cemiplimab, a Human Monoclonal Anti-PD-1, in Patients with Metastatic Cutaneous Squamous Cell Carcinoma. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, p. S79, 2018. DOI: 10.25251/skin.2.supp.79. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/475. Acesso em: 3 jul. 2024.